Skip to main content
OpenTrials
Completed

NCT Number: NCT02092090

China Salt Substitute and Stroke Study

The study is a large scale cluster randomised trial to evaluate the effects of sodium reduction based upon the use of salt substitute on the risk of stroke defined as the occurrence of stroke and stroke deaths. The corresponding null hypothesis that will be tested is that sodium reduction will have no effect upon stroke risk. The secondary objectives are to determine effects of sodium reduction on major vascular events and total mortality.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hebei Province Centre for Disease Control and Prevention, Shijiazhuang, Hebei, China

Loading trial locations.

About this study

Lowering sodium intake and the use of salt substitute have been proved to lower blood pressure levels. Effects on the risks of vascular outcomes have not been defined in an adequately powered randomised trial. Rural Chinese are known to consume very large quantities of sodium and to suffer from very high rates of hypertension and stroke. This study is a large scale cluster randomised trial done in rural areas of China. The study will define the effects of a salt substitute-based sodium reduction strategy on the primary outcome of stroke. Secondary endpoints will include major cardiovascular events and total mortality. The study will be conducted in 600 rural villages across five Northern Chinese provinces and Tibet. The study will recruit 35 individuals at elevated risk of stroke from each village for a total of 21,000 participants. The participating villages will be randomised into intervention and control group with 1:1 allocation. Recruitment will prioritise individuals with a history of stroke but also include older individuals with high blood pressure. Follow up is scheduled for 5 years. Individuals in intervention villages will receive repeated dietary advice and a supply of low sodium salt substitute while individuals in control villages will receive dietary advice at baseline only. Every 6 months throughout follow-up each individual will be contacted by phone call to inquire about the occurrence of stroke, hospitalisation for any cause and diagnoses of any other serious illnesses. The interview will be structured and done by individuals masked to the randomised assignment of each individual. For all deaths identified and all events that might possibly be non-fatal strokes a home visit will be made. A series of process indicators including urinary sodium, urinary potassium, blood pressure, knowledge about sodium and use of salt substitute will also be measured on a random sample of at least 20 individuals drawn from a random selection of 60 villages at baseline and every year thereafter.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Disease history
  • Prior stroke and/or
  • Aged 60 years or over and with uncontrolled high blood pressure (systolic blood pressure >=140 millimeters of mercury (mmHg) at visit if on blood pressure lowering medication; systolic blood pressure>=160 millimeters of mercury (mmHg) if not on blood pressure lowering medication)
  • Ownership of a phone by the participant or a household member

Exclusion criteria

  • Participant or family member is using a potassium-sparing diuretic
  • Participant or family member is using a potassium supplement
  • Participant or family member has serious renal impairment
  • Participant or family member has other reason for concern about use of salt substitute
  • Participant eats most meals outside the home
  • Participant is not expected to live longer than 6 months from the date of assessment as estimated by the village doctor
  • Another family member living in the same household has already been included in the study

Treatment and study plan

Dietary sodium reduction

Behavioral

Ongoing dietary advice and a supply of a reduced-sodium added-potassium salt substitute

Other names: Reduced-sodium added-potassium salt substitute

Primary outcomes

  1. Stroke

    Time frame: 5 years

    The primary outcome will be stroke defined according to standard criteria on the basis of an acute disturbance of focal neurological function and resulting in death or symptoms lasting more than 24 hours. Imaging, clinical and laboratory data will be collected wherever possible.

Secondary outcomes

  1. Total major vascular events

    Time frame: 5 years

    The composite of stroke, acute coronary syndrome or vascular death

  2. Total mortality

    Time frame: 5 years

Other outcomes

  1. Blood Pressure

    Time frame: 5 years

  2. Urinary sodium excretion

    Time frame: 5 years

  3. Urinary Potassium

    Time frame: 5 years

  4. Knowledge about sodium and salt substitute

    Time frame: 5 years

    Knowledge about sodium and salt substitute will be measured using the following questions at baseline and follow-up:.

    Is a high salt intake good for your health? Does how much salt you eat affect your blood pressure? Does how much salt you eat affect your risk of stroke? What is the daily recommended salt intake for adults? Do you try to reduce the amount of salt you eat? Do you eat pickled vegetables most days? Do you add salt to most meals? Do you add mono-sodium glutamate to most meals? Do you try to eat less of a food if it is very salty? Have you heard about low sodium salt? If yes,does your household use low-sodium salt?

Sponsors and collaborators

Lead sponsor

The George Institute

Other

Collaborators

  • Centers for Disease Control and Prevention, China
  • Changzhi Medical College
  • China Medical University, China
  • Imperial College London
  • Ningxia Medical University
  • Northwestern University
  • Peking University
  • Xi'an Jiaotong University

Registry information

Official study title

A LARGE-SCALE CLUSTER RANDOMIZED TRIAL TO DETERMINE THE EFFECTS OF SODIUM REDUCTION ON STROKE: THE CHINA SALT SUBSTITUTE AND STROKE STUDY (SSaSS)

Acronym: SSaSS

Important dates

Study start
2014
Primary completion
2020
Study completion
2020
First posted
Mar 19, 2014
Registry last updated
Apr 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.